Antiretroviral therapy coverage in Paraguay
Paraguay: Antiretroviral therapy coverage was 58.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Paraguay, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Paraguay recorded 58.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
The figure is up 75.8% over ten years.
Over the whole period, antiretroviral therapy coverage in Paraguay peaked at 58.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Paraguay 110th out of 143 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Paraguay, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 7.0% | — |
| 2006 | 10.0% | +42.9% |
| 2007 | 12.0% | +20.0% |
| 2008 | 17.0% | +41.7% |
| 2009 | 21.0% | +23.5% |
| 2010 | 26.0% | +23.8% |
| 2011 | 26.0% | +0.0% |
| 2012 | 27.0% | +3.8% |
| 2013 | 30.0% | +11.1% |
| 2014 | 33.0% | +10.0% |
| 2015 | 35.0% | +6.1% |
| 2016 | 39.0% | +11.4% |
| 2017 | 45.0% | +15.4% |
| 2018 | 47.0% | +4.4% |
| 2019 | 50.0% | +6.4% |
| 2020 | 49.0% | -2.0% |
| 2021 | 52.0% | +6.1% |
| 2022 | 56.0% | +7.7% |
| 2023 | 58.0% | +3.6% |
| 2024 | 58.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.7% | 0.0% | 21.0% | 10 |
| 2010s | 35.8% | 26.0% | 50.0% | 10 |
| 2020s | 54.6% | 49.0% | 58.0% | 5 |
Countries ranked near Paraguay
- 109 North Macedonia 59.0% compare
- 111 Venezuela, Bolivarian Republic of 57.0% compare
- 112 Bahrain 55.0% compare
- 112 Syrian Arab Republic 55.0% compare
More health data for Paraguay
- Un projection of annual infant deaths, annual growth rate -2.02 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2374 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,098 deaths per 1,000 people (2090)
- Number of infants who die before age 1 339 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.5252 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0469 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5185 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Paraguay?
- Antiretroviral therapy coverage in Paraguay was 58.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Paraguay?
- The highest recorded value was 58.0% in 2023.
- What is the lowest antiretroviral therapy coverage recorded in Paraguay?
- The lowest recorded value was 0.0% in 2000.
- How does Paraguay rank for antiretroviral therapy coverage?
- Paraguay ranks 110th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Paraguay?
- Over the last ten years it is up 75.8%. The long-run trend across the full record is volatile.
- Where does this Paraguay data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.